BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37263897)

  • 1. External validation in an Australian population of the EORTC-DeCOG nomogram predicting recurrence, distant metastasis and overall mortality in melanoma patients with positive sentinel lymph nodes.
    Li AT; Law J; Ch'ng S; Scolyer RA; Thompson JF; Lo SN; Varey AHR
    Eur J Cancer; 2023 Aug; 189():112901. PubMed ID: 37263897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EORTC-DeCOG nomogram adequately predicts outcomes of patients with sentinel node-positive melanoma without the need for completion lymph node dissection.
    Verver D; Rekkas A; Garbe C; van Klaveren D; van Akkooi ACJ; Rutkowski P; Powell BWEM; Robert C; Testori A; van Leeuwen BL; van der Veldt AAM; Keilholz U; Stadler R; Eggermont AMM; Verhoef C; Leiter U; Grünhagen DJ
    Eur J Cancer; 2020 Jul; 134():9-18. PubMed ID: 32454396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are the MIA and MSKCC nomograms useful in selecting patients with melanoma for sentinel lymph node biopsy?
    Hosein S; Drebin HM; Kurtansky NR; Olofsson Bagge R; Coit DG; Bartlett EK; Marchetti MA
    J Surg Oncol; 2023 Jun; 127(7):1167-1173. PubMed ID: 36905337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Utility of Melanoma Sentinel Lymph Node Biopsy Nomograms.
    Drebin HM; Hosein S; Kurtansky NR; Nadelmann E; Moy AP; Ariyan CE; Bello DM; Brady MS; Coit DG; Marchetti MA; Bartlett EK
    J Am Coll Surg; 2024 Jan; 238(1):23-31. PubMed ID: 37870230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram.
    Lo SN; Ma J; Scolyer RA; Haydu LE; Stretch JR; Saw RPM; Nieweg OE; Shannon KF; Spillane AJ; Ch'ng S; Mann GJ; Gershenwald JE; Thompson JF; Varey AHR
    J Clin Oncol; 2020 Aug; 38(24):2719-2727. PubMed ID: 32530761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis.
    Ryu JM; Lee SK; Kim JY; Yu J; Kim SW; Lee JE; Han SH; Jung YS; Nam SJ
    Clin Breast Cancer; 2017 Nov; 17(7):550-558. PubMed ID: 28454926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting sentinel node positivity in patients with melanoma: external validation of a risk-prediction calculator (the Melanoma Institute Australia nomogram) using a large European population-based patient cohort.
    El Sharouni MA; Varey AHR; Witkamp AJ; Ahmed T; Sigurdsson V; van Diest PJ; Scolyer RA; Thompson JF; Lo SN; van Gils CH
    Br J Dermatol; 2021 Aug; 185(2):412-418. PubMed ID: 33657653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting recurrence in patients with sentinel node-negative melanoma: validation of the EORTC nomogram using population-based data.
    El Sharouni MA; Ahmed T; Witkamp AJ; Sigurdsson V; van Gils CH; Nieweg OE; Scolyer RA; Thompson JF; van Diest PJ; Lo SN
    Br J Surg; 2021 May; 108(5):550-553. PubMed ID: 34043770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a nomogram to predict recurrence and melanoma-specific mortality in patients with negative sentinel lymph nodes.
    Verver D; van Klaveren D; Franke V; van Akkooi ACJ; Rutkowski P; Keilholz U; Eggermont AMM; Nijsten T; Grünhagen DJ; Verhoef C
    Br J Surg; 2019 Feb; 106(3):217-225. PubMed ID: 30307046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and external validation of a nomogram to predict four or more positive nodes in breast cancer patients with one to three positive sentinel lymph nodes.
    Yang Z; Lan X; Huang Z; Yang Y; Tang Y; Jing H; Wang J; Zhang J; Wang X; Gao J; Wang J; Xuan L; Fang Y; Ying J; Li Y; Huang X; Wang S
    Breast; 2020 Oct; 53():143-151. PubMed ID: 32823167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer.
    Hessman CJ; Naik AM; Kearney NM; Jensen AJ; Diggs BS; Troxell ML; Vetto JT
    Arch Surg; 2011 Sep; 146(9):1035-40. PubMed ID: 21931000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can a machine-learning model improve the prediction of nodal stage after a positive sentinel lymph node biopsy in breast cancer?
    Madekivi V; Boström P; Karlsson A; Aaltonen R; Salminen E
    Acta Oncol; 2020 Jun; 59(6):689-695. PubMed ID: 32148141
    [No Abstract]   [Full Text] [Related]  

  • 13. Validation of a nomogram predicting sentinel lymph node status in melanoma in an Irish population.
    Woods JF; De Marchi JA; Lowery AJ; Hill AD
    Ir J Med Sci; 2015 Dec; 184(4):769-73. PubMed ID: 24997756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A nomogram to predict non-sentinel lymph node metastasis for breast cancer patients with positive axillary sentinel lymph node].
    Yang ZB; Huang Z; Wang SL; Tang Y; Jing H; Wang JY; Zhang JH; Yang Y; Song YW; Fang H; Jin J; Liu YP; Qi SN; Li N; Tang Y; Lu NN; Chen B; Wang X; Gao JD; Wang J; Xuan LX; Fang Y; Li YX
    Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):653-659. PubMed ID: 32867457
    [No Abstract]   [Full Text] [Related]  

  • 15. Predicting Non-sentinel Lymph Node Metastasis in a Chinese Breast Cancer Population with 1-2 Positive Sentinel Nodes: Development and Assessment of a New Predictive Nomogram.
    Chen JY; Chen JJ; Xue JY; Chen Y; Liu GY; Han QX; Yang WT; Shen ZZ; Shao ZM; Wu J
    World J Surg; 2015 Dec; 39(12):2919-27. PubMed ID: 26324157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a nomogram to predict the presence of sentinel lymph node metastases in melanoma.
    Piñero A; Canteras M; Ortiz E; Martínez-Barba E; Parrilla P
    Ann Surg Oncol; 2008 Oct; 15(10):2874-7. PubMed ID: 18648880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of nomograms for predicting axillary non-SLN metastases in breast cancer patients with 1-2 positive sentinel lymph node macro-metastases: a retrospective analysis of two independent cohorts.
    Yu Y; Wang Z; Wei Z; Yu B; Shen P; Yan Y; You W
    BMC Cancer; 2021 Apr; 21(1):466. PubMed ID: 33902502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can We Skip Intraoperative Evaluation of Sentinel Lymph Nodes? Nomogram Predicting Involvement of Three or More Axillary Lymph Nodes before Breast Cancer Surgery.
    Ahn SK; Kim MK; Kim J; Lee E; Yoo TK; Lee HB; Kang YJ; Kim J; Moon HG; Chang JM; Cho N; Moon WK; Park IA; Noh DY; Han W
    Cancer Res Treat; 2017 Oct; 49(4):1088-1096. PubMed ID: 28161935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nomogram to identify high-risk melanoma patients with a negative sentinel lymph node biopsy.
    Bertolli E; de Macedo MP; Calsavara VF; Pinto CAL; Duprat Neto JP
    J Am Acad Dermatol; 2019 Mar; 80(3):722-726. PubMed ID: 30395920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel nomogram for the preoperative prediction of sentinel lymph node metastasis in breast cancer.
    Wang XF; Zhang GC; Zuo ZC; Zhu QL; Liu ZZ; Wu SF; Li JX; Du JH; Yan CL; Ma XY; Shi Y; Shi H; Zhou YD; Mao F; Lin Y; Shen SJ; Zhang XH; Sun Q
    Cancer Med; 2023 Mar; 12(6):7039-7050. PubMed ID: 36524283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.